Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...

Cupid shares fell sharply on Fridat after a 13-session unbeaten rally, driven by heavy profit booking and strong volumes. The stock, which ...

The Indian government is considering lowering tariffs on US medical devices to mitigate potential US tariff threats on Indian exports. Whil...

India's Drugs Technical Advisory Board decides against waiving clinical trials for In-vitro Diagnostics despite their approval in other cou...

Till now, foreign-sourced goods used to dominate the medical consumables and disposables market in the country. In the fiscal year 2022-23,...

For the full year, net profit rose 26% to Rs 39.85 crore against Rs 31.58 crore during the previous fiscal.

"In the medical devices sector, a lot of issues related to rules of origin are still there. Demand for customs duty concessions is also the...

The open offer follows Universal-Halwasiya Group and Family through Columbia Petro Chem Private Limited and Halwasiya, entering into a defi...

The healthcare company will manufacture high-quality rapid antigen test kits at its ICMR approved GMP and ISO certified facility at Vasai, ...

Spread over 20,000 sq ft area, the IVD manufacturing facility is equipped with state-of-the-art technologies and infrastructure of global s...

Roche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for India...

Domestic manufacturers of rapid antibody rapid test kits for novel coronavirus have approached the Indian Council of Medical Research (ICMR...

Roche Diagnostics is part of Swiss healthcare major Roche. It sells devices and equipment to labs and hospitals and is mainly present in th...

Trivitron Chairman and Managing Director G S K Velu said: "We have invested 5 million euros for picking up the stake including share premiu...

Agappe Diagnostic Limited is planning to tap the tier 2 and 3 markets by expanding its production capacities.

Arkray has entered into an agreement to buy out the in-vitro diagnostics business of Surat-based Span Diagnostics for close to Rs 100 crore.

Medical technology company Trivitron has forged an alliance with BioSystems of Spain to manufacture IVD Reagents.